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Abstract 
 
Hypertension (HTN) is the most common chronic disease in the U.S., and the standard 
model of office-based care delivery has yielded suboptimal outcomes, with 
approximately 50% of affected patients not achieving blood pressure (BP) control.  Poor 
population-level BP control has been primarily attributed to therapeutic inertia and low 
patient engagement.  New models of care delivery utilizing patient-generated health 
data, comprehensive assessment of social health determinants, computerized 
algorithms generating tailored interventions, frequent communication and reporting, 
and non-physician providers organized as an integrated practice unit, have the potential 
to transform population-based HTN control.  This review will highlight the importance of 
these elements and construct the rationale for a reengineered model of care delivery 
for populations with HTN. 
 
 
 
 
 
Abbreviations: 
 
BP = Blood pressure 
CV = Cardiovascular 
HTN = Hypertension 
IPU = Integrated practice unit 
PGHD = Patient-generated health data  
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Introduction 
Hypertension (HTN) remains the most common chronic condition, affecting 30% of U.S. 
adults and is the leading diagnoses made during a primary care office visit. (1) In the U.S. 
alone, the estimated annual cost of HTN exceeds $50 billion, and across the globe, HTN 
is responsible for approximately 10% of all healthcare spending. (2,3) Roughly half of 
individuals with HTN have not achieved guideline-recommended blood pressure (BP) 
targets; as a result, HTN is one of the nation’s leading causes of death, responsible for 
one in six deaths among adults annually. Additionally, uncontrolled HTN increases non-
fatal myocardial infarction and stroke and remains the second leading cause of renal 
failure.  Since the year 2000, HTN-related deaths in the U.S. have risen by 23% whereas 
all other causes of death combined over this same period have fallen by 21%.(4) 
Achieving improved population-based BP control remains a primary objective of public 
health policy and healthcare financing organizations across the globe yet efforts have 
been limited to minor adjustments in the current model of office-based care delivery. 
(5,6) 
 
Improving Hypertension Control in the Population 
Why such a large percentage of HTN patients fail to achieve BP control remains an area 
of intense interest.  When comparing patients with controlled versus uncontrolled HTN, 
routine characteristics such as age, gender, health insurance, and visit frequency are 
remarkably similar.  In NHANES III, 92% of patients with uncontrolled HTN possessed 
health insurance, and 86% reported a regular source of healthcare.(7)  In fact, patients 
with uncontrolled HTN saw their physician an average of 4.3 times per year, a frequency 
similar to that of patients with controlled HTN. What is noteworthy however, is in only 
22-38% of these visits was pharmacologic therapy either started or intensified. The 
failure to augment therapy in order to achieve disease-specific treatment goals has been 
coined “therapeutic inertia”, and consists of three domains of responsibility: the 
clinician, the patient, and the healthcare system.(8) (Table 1) When evaluating patients 
with uncontrolled HTN, the prevalence of therapeutic inertia has been reported to be as 
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high as 87% of provider visits, thus offering the potential for quality improvement 
initiatives targeting this shortcoming in clinical care.(9) This failure at the provider level 
can be ameliorated by use of guideline-based protocols executed by non-physician 
providers working in a “focused-factory” model of care delivery.(8) Organizing care 
utilizing specialized integrated practice units (IPU), offers such a potential.   
 
An IPU utilizes non-physician personnel dedicated to a specific disease condition for the 
full cycle of care. (10,11) Members of the care team may include pharmacists, advanced 
practice clinicians, nurses, health educators, dieticians, social workers, counselors and 
therapists, all organized around the patient’s medical condition. In this model, patients 
can be more frequently and effectively connected to the health delivery system utilizing 
apps as well as home-based and wearable devices, and communication can be 
consistent and at regular intervals between the care team and the patient.(8) Patients 
can achieve a higher level of engagement in the care process via enhanced education, 
real-time feedback via wearable and home-based devices, and enriched communication 
with both the care team and other patients via social networks, thus achieving high 
satisfaction and improved outcomes within the healthcare system. (Figure 1) 
 
The Role of Patient-Generated Health Data in Hypertension Management 
Home BP collection has been endorsed by many HTN guidelines, and addresses several 
limitations of traditional office-based care, including a larger sample of biologic data, 
reducing misclassification due to white-coat or masked HTN, and an ability to take more 
timely action and course correct therapy. (12-15)  Home measurements better predict 
cardiovascular (CV) risk than do office measurements, are more reproducible, and show 
better correlation with measures of target organ damage. (12) Current consumer 
technology is accurate, reliable, easy to use and relatively inexpensive.  Moreover, home 
BP readings now have the capability of directly populating the patient’s electronic 
medical record, and no longer necessitate each patient generating a handwritten diary 
of readings to bring to their provider. (16) Data can be safely transmitted through a 
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Health Insurance Portability and Accountability Act (HIPAA)-secure enterprise portal, 
such as Apple’s HealthKit®.(16) Additionally, home BP measurements can be visually 
displayed over time in various consumer-facing smartphone apps (such as Apple Health, 
Withings, iHealth) and have been demonstrated to independently enhance patient 
engagement and improve medication adherence. (1,17) The need to engage patients is 
now recognized as a primary strategy in chronic disease care, the importance of which 
highlighted via development of a “Patient Engagement Playbook” by the Office of the 
National Coordinator for Health IT (ONC). (12,16,18,19) Improving patient engagement 
not only improves overall patient satisfaction, an important strategy in the environment 
of HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) and 
CGCAHPS (Clinician and Group Consumer Assessment of Healthcare providers and 
Systems), but also improves medication adherence in patients with chronic conditions, 
and further, reduces the risk of medical errors. (20) Strategies that encompass patient-
generated health data (PGHD) together with focused efforts to enhance patient 
engagement have shown efficacy in improving outcomes in chronic disease. (16,21) 
 
Phenotyping the Patient with Hypertension: The Importance of Precision 
Medicine 
Managing patients with chronic disease including HTN must include factors that play a 
role in achieving long-term, disease-based outcomes.  These often include 
considerations that lie outside the traditional domain of the medical record. (Table 2)  
Based on the resulting patient phenotype, therapy and interventions can be directed 
that are tailored to the individual’s unique circumstance. For instance, education 
programs and even prescription labeling can be adjusted based on health literacy, and 
focused interventions towards increasing patient activation can be promoted in 
populations with reduced medication adherence.  Altering medications to generics 
and/or enrolling patients in patient assistance programs can help those with difficulties 
in paying for medicine, and inclusion of food preparers in dietary sodium education can 
significantly influence overall sodium consumption.  All these efforts can dramatically 
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assist in achieving BP control, and can be best achieved using an IPU model where 
comprehensive assessment and focused care delivery impacting lifestyle and 
pharmacologic management is available without the constraints of a 15-minute office 
visit.   
 
Population-Directed Efforts in Hypertension Management 
Timely communication and feedback can also play a large role in population-based 
efforts towards HTN control.  Communication can include regular progress reports 
towards achieving BP goals as well as tips promoting and/or reinforcing lifestyle change. 
(Figure 2).  Communicating test results is also highly desired among patients with 
chronic disease and is typically mediated via a password-protected patient portal. (22)  
Lifestyle-focused texts offering advice, motivational reminders and support has also 
been shown to be effective in improving HTN and other chronic diseases. (23) 
Up to 40 percent of patients with chronic conditions desire medication reminders, and 
today, these can be easily employed using many user-friendly free apps available on 
smartphones and smart-watches (i.e. Apple Watch)(Figure 3). (24)  Many of these apps 
are interactive, providing a means for providers to monitor medication adherence and 
refill needs.   
 
Large volumes of PGHD including home BP readings can be loaded into computer 
algorithms within the electronic medical record that can highlight which patients need 
what type of support and when.  This can include advice, encouragement, lifestyle tips 
or medication adjustment; all delivered via the IPU in near real-time.  Providing this 
comprehensive approach to population HTN management has now been demonstrated 
to be more effective than routine office-based management. (25)   
 
Recent Study 
In a study comparing patients with uncontrolled HTN, more patients achieved BP control 
within 90 days using a digital-IPU model as described, compared to those managed 
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conventionally. Table 3 describes the changes in BP metrics and other health metrics at 
90 days in the digital-IPU model (a) and Usual Care (b) groups.  BP including systolic, 
diastolic, mean arterial pressure, and pulse pressure improved significantly in both 
groups (p<0.001).  Moreover, at 90 days, 71% of patients in the digital-IPU group 
achieved BP control compared to 31% of Usual Care patients (p<0.001).  Over the 90-
day period, the Usual Care group had an average of 3 ± 0.2 BP recordings in the 
electronic medical record compared to 161 ± 150 recordings (averaging 4.2/week) in the 
digital-IPU group (p<0.001), who submitted BP data directly from home to the electronic 
medical record. 
Patients received monthly reports, text reminders, and frequent interactions with the 
IPU care team, made up of clinical pharmacists and health coaches.  Patient activation 
improved overall, as reflected by a 60% reduction in percent of patients with low patient 
activation.  It is noteworthy that the mean age of the digital medicine cohort was 68 
years, suggesting that use of technology from home was not a deterrent for an elderly 
population.  
The differences highlighted between office-based care dispersed several times per year 
and a more continual care model are not trivial, and were accompanied by improved 
quality and engagement.  Additionally, this model of precision-based, highly interactive 
care is cost-effective and is applicable across broad populations regardless of geographic 
distribution. 
 
Conclusion 
HTN management using an office-based model of care delivery has demonstrated 
suboptimal results in population level BP control, patient engagement, and HTN-related 
clinical outcomes.  New models of care delivery, incorporating PGHD, high levels of 
patient connectivity and communication, tailored interventions incorporating individual 
social determinants, all administered through an IPU model, has been demonstrated to 
yield superior BP control, while at the same time achieving higher levels of patient 
engagement.  Health delivery systems should reengineer care delivery to better meet 
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the needs of the population they serve by incorporating new technologies and modes of 
patient interaction that focus on the real-time, continuous management of chronic 
conditions. 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
New Concepts in Hypertension Management 
 
 9 
References 
 
1. Margolis KL, Asche SE, Bergdall AR et al. Effect of home blood pressure 
telemonitoring and pharmacist management on blood pressure control: a cluster 
randomized clinical trial. JAMA : the journal of the American Medical Association 
2013;310:46-56. 
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global 
burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23. 
3. Gaziano TA, Bitton A, Anand S, Weinstein MC, International Society of H. The 
global cost of nonoptimal blood pressure. J Hypertens 2009;27:1472-7. 
4. Kung HC, Xu J. Hypertension-related Mortality in the United States, 2000-2013. 
NCHS data brief 2015:1-8. 
5. Pearson TA, Palaniappan LP, Artinian NT et al. American Heart Association Guide 
for Improving Cardiovascular Health at the Community Level, 2013 update: a 
scientific statement for public health practitioners, healthcare providers, and 
health policy makers. Circulation 2013;127:1730-53. 
6. A Population-Based Policy and Systems Change Approach to Prevent and Control 
Hypertension. Institure of Medicine. Washington (DC), 2010. 
7. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension 
in the United States. The New England journal of medicine 2001;345:479-86. 
8. Milani RV, Lavie CJ. Healthcare 2020: Reengineering Healthcare Delivery to 
Combat Chronic Disease. The American journal of medicine 2015;128:337-343. 
9. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. 
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood 
pressure control goals. Hypertension 2006;47:345-51. 
10. Porter ME. A strategy for health care reform--toward a value-based system. The 
New England journal of medicine 2009;361:109-12. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
New Concepts in Hypertension Management 
 
 10 
11. Porter ME, Pabo EA, Lee TH. Redesigning primary care: a strategic vision to 
improve value by organizing around patients' needs. Health affairs 2013;32:516-
25. 
12. Pickering TG, Miller NH, Ogedegbe G et al. Call to action on use and 
reimbursement for home blood pressure monitoring: executive summary: a joint 
scientific statement from the American Heart Association, American Society Of 
Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 
2008;52:1-9. 
13. Aronow WS, Fleg JL, Pepine CJ et al. ACCF/AHA 2011 expert consensus document 
on hypertension in the elderly: a report of the American College of Cardiology 
Foundation Task Force on Clinical Expert Consensus documents developed in 
collaboration with the American Academy of Neurology, American Geriatrics 
Society, American Society for Preventive Cardiology, American Society of 
Hypertension, American Society of Nephrology, Association of Black Cardiologists, 
and European Society of Hypertension. Journal of the American College of 
Cardiology 2011;57:2037-114. 
14. Parati G, Stergiou GS, Asmar R et al. European Society of Hypertension practice 
guidelines for home blood pressure monitoring. J Hum Hypertens 2010;24:779-
85. 
15. Tientcheu D, Ayers C, Das SR et al. Target Organ Complications and 
Cardiovascular Events Associated With Masked Hypertension and White-Coat 
Hypertension: Analysis From the Dallas Heart Study. Journal of the American 
College of Cardiology 2015;66:2159-69. 
16. Milani RV, Bober RM, Lavie CJ. The Role of Technology in Chronic Disease Care. 
Progress in cardiovascular diseases 2016;58:579-83. 
17. Mc Namara KP, Versace VL, Marriott JL, Dunbar JA. Patient engagement 
strategies used for hypertension and their influence on self-management 
attributes. Fam Pract 2014;31:437-44. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
New Concepts in Hypertension Management 
 
 11 
18. Office of the National Coordinator for Health IT. Patient Engagement Playbook. 
2016. Available at: https://www.healthit.gov/playbook/pe/  Last assessed: 
August 22, 2016. 
19. Carman KL, Dardess P, Maurer M et al. Patient and family engagement: a 
framework for understanding the elements and developing interventions and 
policies. Health affairs 2013;32:223-31. 
20. Hibbard JH, Greene J. What the evidence shows about patient activation: better 
health outcomes and care experiences; fewer data on costs. Health affairs 
2013;32:207-14. 
21. Moore JO, Marshall MA, Judge DC, Moss FH, Gilroy SJ, Zusman RM. Technology-
Supported Apprenticeship in the Management of Hypertension: A Randomized 
Controlled Trial. Journal of Clinical Outcomes Management 2014;21:110-122. 
22. LaRocque JR, Davis CL, Tan TP, D'Amico FJ, Merenstein DJ. Patient Preferences 
for Receiving Reports of Test Results. J Am Board Fam Med 2015;28:759-66. 
23. Chow CK, Redfern J, Hillis GS et al. Effect of Lifestyle-Focused Text Messaging on 
Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized 
Clinical Trial. JAMA : the journal of the American Medical Association 
2015;314:1255-63. 
24. Mobile Thought Leadership.  FICO 2013. Available at: 
https://www.remindercall.com/download/FICO_Mobile_Thought_Leadership_B
rief_US_3036EX.pdf  Last assessed: August 31, 2016. 
25. Milani RV, Lavie CJ, Bober RM, Milani AR, Ventura HJ. Improving Hypertension 
Control and Patient Engagement Using Digital Tools. The American journal of 
medicine 2016 (in press). 
 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
New Concepts in Hypertension Management 
 
 12 
Table 1: Factors leading to therapeutic inertia and methods to enhance therapeutic 
activation 
 
 
 
CDS = clinical decision support, CV = cardiovascular, EMR = electronic medical record, IPU = 
integrated practice unit 
 
Therapeutic Inertia   Therapeutic Activation 
Clinician     
Failure to initiate treatment   Guideline-based therapy using non-physician providers 
Failure to titrate to goal   Guideline-based therapy using non-physician providers 
Failure to set clear goals   Co-creation of treatment plan with patient 
Underestimation of patient need   Needs assessment upon enrollment 
Failure to identify & manage 
comorbidities   Screen for related co-morbidities 
Insufficient time   IPU-model of care delivery 
Insufficient focus on goal attainment   IPU-model of care delivery 
Reactive rather than proactive   Weekly patient-generated health data 
Patient     
Medication side-effects   Screening and close follow-up by care team 
Too many medications   Medication simplification by clinical pharmacist 
Cost of medications   Screening for medication affordability, 
    use of generic alternatives, patient assistance programs 
Denial of disease   Disease-focused education, patient engagement 
Denial of disease severity   Disease-focused education, patient engagement 
Forgetfulness   Medication reminders (apps, pill boxes, etc.) 
Perception of low susceptibility   Develop concept of total CV risk 
Absence of disease symptoms   Develop concept of total CV risk, patient education 
Poor communication with MD   Monthly reports to patient, routine calls 
Mistrust of clinician   Work towards building trust, regular communication 
Depression, mental illness, substance 
abuse   Screening for depression, substance abuse 
Low health literacy 
  
Screening for health literacy; use of modified education, Rx. 
labeling 
Health System     
Lack of clinical guideline   Use of current evidence-based guidelines 
Lack of care coordination   IPU creates single point of contact 
No visit planning   Calls and outreach built into EMR 
Lack of decision support   CDS tools guide which patients need what help, when 
Poor communication between MD & staff   Monthly reports to patients and providers, routine calls 
No disease registry   Registry created in EMR 
No active outreach   IPU creates active outreach to patient's home 
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Table 2: Screening attributes necessary to phenotype the patient with hypertension 
 
 Dietary sodium consumption 
 Medication adherence 
 Social circumstances (number in household, support system, meal preparation, 
etc.) 
 Medication affordability 
 Depression 
 Alcohol consumption 
 Patient engagement/activation 
 Physical activity index 
 Health literacy 
 Sleep apnea screening survey 
 Laboratory assessment (glomerular filtration rate, CO2, sodium, thyroid function) 
 Co-morbid conditions (i.e. diabetes) 
 Cardiovascular risk factors (i.e. smoking, dyslipidemia, etc.) 
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Table 3 
 
(a) Changes in blood pressure and health metrics in the Digital Medicine/IPU model 
group at 90 days (n=156). 
 
 Baseline 90-days p-value 
Systolic blood pressure (mmHg) 147 ± 19 133 ± 12 <0.001 
Diastolic blood pressure (mmHg) 81 ± 12 76 ± 9 <0.001 
Mean arterial pressure (mmHg) 103 ± 12 95 ± 9 <0.001 
Pulse pressure (mmHg) 66 ± 16 57 ± 11 <0.001 
High dietary sodium intake (%) 32% 8% 0.004 
Patient activation score 41.9 ± 6.6 44.1 ± 6.7 0.008 
Low patient activation (%) 15% 6% 0.03 
 
 
 
(b) Changes in BP metrics in the Office-based Usual Care group at 90 days (n=400). 
 
 Baseline 90-days p-value 
Systolic blood pressure (mmHg) 147 ± 5 143 ± 14 <0.001 
Diastolic blood pressure (mmHg) 81 ± 8 79 ± 9 <0.001 
Mean arterial pressure (mmHg) 103 ± 6 100 ± 7 <0.001 
Pulse pressure (mmHg) 65 ± 9 63 ± 9 <0.001 
 
 
From Milani, RV, et al. Am J Med. 2016 (in press). 
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Figure 1 
 
Use of patient-generated health data in conjunction with an integrated practice unit in 
the management of hypertension. 
 
 
 
 
From: Milani RV, Bober RM, Lavie CJ. Prog Cardiovasc Dis. 2016; 58:579-83.
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Figure 2 
 
Monthly patient report in a hypertension digital medicine program 
 
 
 
 
 
 
From Milani, RV, et al. Am J Med. 2016 (in press). 
 
 
  
December 2014
Test Patient
Hypertension Digital Medicine Report
High blood pressure, also called hypertension, occurs when the pressure inside your arteries is higher than 
it should be.  One in three American adults has high blood pressure, and if it is not controlled, it can cause 
damage to your eyes, brain, heart, blood vessels and kidneys; as a result, high blood pressure is a leading 
cause of heart attack and stroke.   High blood pressure has no warning signs or symptoms, so monitoring 
your blood pressure readings and getting it under control  is very important to your health and well-being.
What is High Blood Pressure?
Your Results
Try these physical activities to reduce your blood 
pressure:
•    Take your children or grandchildren to the 
park.
•    Take a 30-minute window-shopping walk 
around the mall when weather is bad. 
Did you know that the more alcohol you drink, the 
higher your blood pressure?  The good news is that 
by reducing your alcohol intake, ideally to less than 2 
alcoholic drinks per day, you can effectively lower 
blood pressure.
if your HDL cholesterol was at least 60 mg/dL
if your blood pressure was 120 mm/Hg
With your current medical
conditions, the 10 year estimated
risk of heart attack and stroke is:
You can reduce your risk to:
10%
6%
Your Progress
87
<60 60-89 90-110
DangerLow Desired High
>110
Danger
90-139 140-180 >180
Low
<90
HighDesired
Your Risk
138
Systolic
Diastolic
Excellent
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Figure 3 
 
Example of medication reminders available for the smartphone and smart-watch. 
 
 
 
 
 
